Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

被引:73
作者
Arafat, A. M. [1 ,2 ]
Kaczmarek, P. [3 ]
Skrzypski, M. [3 ,4 ,5 ]
Pruszynska-Oszmalek, E. [3 ]
Kolodziejski, P. [3 ]
Szczepankiewicz, D. [3 ]
Sassek, M. [3 ,4 ,5 ]
Wojciechowicz, T. [3 ]
Wiedenmann, B. [4 ,5 ]
Pfeiffer, A. F. H. [1 ,2 ]
Nowak, K. W. [3 ]
Strowski, M. Z. [4 ,5 ]
机构
[1] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany
[2] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Nuthetal, Germany
[3] Poznan Univ Life Sci, Dept Anim Physiol & Biochem, Poznan, Poland
[4] Charite, Dept Gastroenterol & Hepatol, Campus Virchow Klinikum, D-13353 Berlin, Germany
[5] Charite, Interdisciplinary Ctr Metab Endocrinol Diabet & M, Campus Virchow Klinikum, D-13353 Berlin, Germany
关键词
Adipocytes; Animal study; Endocrine pancreas; Glucose homeostasis; Hepatocytes; Human study; Secretion; Type; 1; diabetes; FREE FATTY-ACIDS; PPAR-ALPHA; METABOLIC SYNDROME; GHRELIN SECRETION; RECEPTOR; ADIPOCYTES; FGF-21; FIBROBLAST-GROWTH-FACTOR-21; SENSITIVITY; EXPRESSION;
D O I
10.1007/s00125-012-2803-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and energy expenditure. All these physiological processes are also controlled by fibroblast growth factor 21 (FGF-21), a circulating hepatokine that improves the metabolic profile in obesity and type 2 diabetes. Animal experiments have suggested a possible interaction between glucagon and FGF-21 however, the metabolic consequences of this crosstalk are not understood. The effects of exogenous glucagon on plasma FGF-21 levels and lipolysis were evaluated in healthy volunteers and humans with type 1 diabetes, as well as in rodents with streptozotocin (STZ)-induced insulinopenic diabetes. In vitro, the role of glucagon on FGF-21 secretion and lipolysis was studied using isolated primary rat hepatocytes and adipocytes. Fgf-21 expression in differentiated rat pre-adipocytes was suppressed by small interfering RNA and released FGF-21 was immunoneutralised by polyclonal antibodies. Glucagon induced lipolysis in healthy human volunteers, patients with type 1 diabetes, mice and rats with STZ-induced insulinopenic diabetes, and in adipocytes isolated from diabetic and non-diabetic animals. In addition, glucagon increased circulating FGF-21 in healthy humans and rodents, as well as in patients with type 1 diabetes, and insulinopenic rodents. Glucagon stimulated FGF-21 secretion from isolated primary hepatocytes and adipocytes derived from animals with insulinopenic diabetes. Furthermore, FGF-21 stimulated lipolysis in primary adipocytes isolated from non-diabetic and diabetic rats. Reduction of Fgf-21 expression (by approximately 66%) or immunoneutralisation of released FGF-21 markedly attenuated glucagon-stimulated lipolysis in adipocytes. These results indicate that glucagon increases circulating FGF-21 independently of endogenous insulin levels. FGF-21 participates in glucagon-induced stimulation of lipolysis.
引用
收藏
页码:588 / 597
页数:10
相关论文
共 36 条
[1]   Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level [J].
Arafat, A. M. ;
Perschel, F. H. ;
Otto, B. ;
Weickert, M. O. ;
Rochlitz, H. ;
Schoefl, C. ;
Spranger, J. ;
Moehlig, M. ;
Pfeiffer, A. F. H. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3528-3533
[2]   Glucagon inhibits ghrelin secretion in humans [J].
Arafat, MA ;
Otto, B ;
Rochlitz, H ;
Tschöp, M ;
Bähr, V ;
Möhlig, M ;
Diederich, S ;
Spranger, J ;
Pfeiffer, AFH .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (03) :397-402
[3]   FGF21 attenuates lipolysis in human adipocytes -: A possible link to improved insulin sensitivity [J].
Arner, Peter ;
Pettersson, Amanda ;
Mitchell, Pamela J. ;
Dunbar, James D. ;
Kharitonenkov, Alexei ;
Ryden, Mikael .
FEBS LETTERS, 2008, 582 (12) :1725-1730
[4]  
Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
[5]   Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity [J].
Berger, J ;
Tanen, M ;
Elbrecht, A ;
Hermanowski-Vosatka, A ;
Moller, DE ;
Wright, SD ;
Thieringer, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12629-12635
[6]   RETRACTED: Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo(Retracted article. See vol.311,pg.E850,2016) [J].
Berglund, Eric D. ;
Kang, Li ;
Lee-Young, Robert S. ;
Hasenour, Clinton M. ;
Lustig, Daniel G. ;
Lynes, Sara E. ;
Donahue, E. Patrick ;
Swift, Larry L. ;
Charron, Maureen J. ;
Wasserman, David H. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2010, 299 (04) :E607-E614
[7]   Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity [J].
Berglund, Eric D. ;
Li, Candice Y. ;
Bina, Holly A. ;
Lynes, Sara E. ;
Michael, M. Dodson ;
Shanafelt, Armen B. ;
Kharitonenkov, Alexei ;
Wasserman, David H. .
ENDOCRINOLOGY, 2009, 150 (09) :4084-4093
[8]   Growth Hormone Induces Hepatic Production of Fibroblast Growth Factor 21 through a Mechanism Dependent on Lipolysis in Adipocytes [J].
Chen, Wei ;
Hoo, Ruby Lai-chong ;
Konishi, Morichika ;
Itoh, Nobuyuki ;
Lee, Pui-chi ;
Ye, Hong-ying ;
Lam, Karen Siu-ling ;
Xu, Aimin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (40) :34559-34566
[9]  
Cherrington AD, 1997, CLIN RES DIABETES OB, V1, P221
[10]   EFFECTS OF NUTRITIONAL STATE, INSULIN, AND GLUCAGON ON LIPID MOBILIZATION IN RAINBOW-TROUT, ONCORHYNCHUS-MYKISS [J].
HARMON, JS ;
SHERIDAN, MA .
GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1992, 87 (02) :214-221